An interdisciplinary team of 14 experts from Departments II, V, and VIII collaborates to develop novel bioactive molecules for medical applications.

In addition, 16 doctoral researchers are actively involved in the consortium’s ongoing research projects, pursuing their PhDs in cooperation with various universities.